Vascular Solutions Inc. (NSDQ:VASC) on Tuesday reported its seventh consecutive year of double-digit revenue growth.
“The fourth quarter completed another very successful year for Vascular Solutions,” CEO Howard Root said in prepared remarks.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
A roundup of companies announcing mergers and acquisitions.
Howard Root wants you to know that he’s not an angry man. Really.
Yes, the CEO of Vascular Solutions Inc. (NSDQ:VASC) sued another company for product defamation (Vascular won $3.5 million), tangled with local reporters (not me, at least not yet), and threatened not to develop any new products with Minnesota doctors if the state passed a disclosure bill (the legislation died).
Vascular Solutions Inc. (NSDQ:VASC) paid $5.75 million for a pair of vein-access technologies used in ultrasound procedures.
The Minneapolis-based company expects the new products to begin paying immediate dividends and upped its full-year sales guidance by $2 million.
Vascular Solutions Inc. (NSDQ:VASC) posted fourth-quarter sales of $17.7 million for the three months ended Dec. 31, 2009, up 10.3 percent compared with $16.1 million during the same period in 2008. Net income fell 89 percent to $1.6 million, compared with $14.7 million during Q4 2008: